S-nitrosylation of Cdk5 Potential implications in amyloid-β-related neurotoxicity in Alzheimer disease

被引:35
|
作者
Qu, Jing [1 ]
Nakamura, Tomohiro [1 ]
Holland, Emily A. [1 ]
McKercher, Scott R. [1 ]
Lipton, Stuart A. [1 ]
机构
[1] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA
关键词
nitrosative stress; cyclin-dependent kinase 5; nitric oxide; neuronal NO synthase; transnitrosylation; CYCLIN-DEPENDENT KINASE-5; DOMINANT OPTIC ATROPHY; NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL FISSION; PARKINSONS-DISEASE; P25/CYCLIN-DEPENDENT KINASE-5; OXIDATIVE STRESS; NMDA RECEPTORS; TAU-PROTEIN; MOUSE MODEL;
D O I
10.4161/pri.21250
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant activation of Cdk5 has been implicated in the process of neurodegenerative diseases such as Alzheimer disease (AD). We recently reported that S-nitrosylation of Cdk5 (forming SNO-Cdk5) at specific cysteine residues results in excessive activation of Cdk5, contributing to mitochondrial dysfunction, synaptic damage and neuronal cell death in models of AD. Furthermore, SNO-Cdk5 acts as a nascent S-nitrosylase, transnitrosylating the mitochondrial fission protein Drp1 and enhancing excessive mitochondrial fission in dendritic spines. However, a molecular mechanism that leads to the formation of SNO-Cdk5 in neuronal cells remained obscure. Here, we demonstrate that neuronal nitric oxide synthase (NOS1) interacts with Cdk5 and that the close proximity of the two proteins facilitates the formation of SNO-Cdk5. Interestingly, as a negative feedback mechanism, Cdk5 phosphorylates and suppresses NOS1 activity. Thus, together with our previous report, these findings delineate an S-nitrosylation pathway wherein Cdk5/NOS1 interaction enhances SNO-Cdk5 formation, mediating mitochondrial dysfunction and synaptic loss during the etiology of AD.
引用
收藏
页码:364 / 370
页数:7
相关论文
共 50 条
  • [31] The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease
    Dyer, Ryan R.
    Ford, Katarena I.
    Robinson, Rena A. S.
    POST-TRANSLATIONAL MODIFICATIONS THAT MODULATE ENZYME ACTIVITY, 2019, 626 : 499 - 538
  • [32] Neuroprotective effect of TNFα against the β-amyloid neurotoxicity mediated by CDK5 kinase
    Orellana, Daniel I.
    Quintanilla, Rodrigo A.
    Maccioni, Ricardo B.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (02): : 254 - 263
  • [33] Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer's Disease
    Kim, Dong Eun
    Priefer, Ronny
    BRAIN SCIENCES, 2020, 10 (02)
  • [34] The Diagnostic Potential of Circulating Autoantibodies to Amyloid-β in Alzheimer's Disease
    Xu, Guang-Yu
    Liu, Yu-Hao
    Zeng, Xiao-Qin
    Chen, Dong-Wan
    Zeng, Gui-Hua
    Fan, Dong-Yu
    Liu, Yu-Hui
    Wang, Yan-Jiang
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 537 - 546
  • [35] Animal models of amyloid-β-related pathologies in Alzheimer's disease
    Philipson, Ola
    Lord, Anna
    Gumucio, Astrid
    O'Callaghan, Paul
    Lannfelt, Lars
    Nilsson, Lars N. G.
    FEBS JOURNAL, 2010, 277 (06) : 1389 - 1409
  • [36] CDK5: The Connection Between Alzheimer's Disease and Type 2 Diabetes?
    Mora, Kevin Edgar
    Aguanno, Ann
    FASEB JOURNAL, 2018, 32 (01):
  • [37] Intracellular amyloid-β in Alzheimer's disease
    LaFerla, Frank M.
    Green, Kim N.
    Oddo, Salvatore
    NATURE REVIEWS NEUROSCIENCE, 2007, 8 (07) : 499 - 509
  • [38] Role of amyloid-β in Alzheimer's disease
    Smith, MA
    Perry, G
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 131 - 131
  • [39] Amyloid-β Immunotherapy for Alzheimer's Disease
    Fu, H. J.
    Liu, B.
    Frost, J. L.
    Lemere, C. A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (02) : 197 - 206
  • [40] Amyloid-β hypothesis of Alzheimer's disease
    Shearman, MS
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 187 - 190